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dures performed by a single vascular surgeon before (period 1, October
2009 to April 2012) and after (period 2, May 2012 to December 2013)
the protocol initiation. The protocol included favoring the brachiocephalic
(BC) location unless the patient was an ideal anatomic candidate for a radio-
cephalic (RC) AVF, creating a larger and standardized arteriotomy, and use
of a large venous footplate whenever possible. The main outcome measure
was failure to achieve maturation. Secondary outcomes were type of ﬁstula,
steal syndrome, time to maturation, and central catheter infections.
Results: Of 232 vascular access procedures that were performed,
90.1% were AVFs. There was no difference in use of AVFs over AV grafts
between period 1 (93% AVFs) and period 2 (86% AVFs, P ¼ .1). Of 209
AVF, 11 patients (5.3%) were lost to follow-up and 7 (3.3%) were awaiting
a second stage procedure, leaving 191 patients with maturation data
(Table). BC AVF was performed more often in period 2 (P ¼ .01), with
a trend toward decreased use of RC AVF (P ¼ .06). Median arteriotomy
size in period 2 was 7 mm. Failure of maturation was signiﬁcantly decreased
in period 2 (odds ratio, 5.0; 95% conﬁdence interval, 1.2-inﬁnite;, P ¼ .03),
as was the incidence of central catheter infections (P ¼ .006). There was no
difference in steal syndrome (P ¼ 1.0) or time to maturation (P ¼ .3).
Conclusions: Creating a standardized AVF protocol resulted in a sig-
niﬁcant decrease in the rate of AVF failure. This was achieved while main-
taining the same high percentage of ﬁstulas, a lower rate of central
catheter infections, and the same low incidence of steal syndrome. We
were able to decrease rates of AVF failure by following strict anatomic
guidelines, including preferential migration to BC location, generous arte-
riotomy, and use of a large venous footplate.Table. Comparison of arteriovenous ﬁstula data between study periods
Period 1
(n ¼ 94)
Period 2
(n ¼ 97)
OR
(95% CI) P
Male gender, No. (%) 64 (68) 64 (66) 1.1 (0.6-2.0) .8
Brachiocephalic, No. (%) 35 (37) 54 (56) 0.6 (0.3-0.8) .01
Radiocephalic, No. (%) 34 (36) 22 (23) .06
Superﬁcialization,
No. (%)
25 (27) 20 (21) 1.4 (0.7-2.7) .3
Diabetes, No. (%) 65 (69) 60 (62) 1.4 (0.8-2.5) .3
Tobacco use, No. (%) 10 (11) 4 (4) 2.8 (0.8-9.2) .1
Maturation time,
median (IQR) days
69 (45-110) 56 (44-106) .3
Failure of Maturation,
No. (%)
9 (10) 2 (2) 5 (1.1-23.9) .03
Steal, No. (%) 3 (3) 4 (4) 0.8 (0.2-3.5) 1
Central catheter
infection, No. (%)
7 (7) 0 NA .006
CI, conﬁdence interval; IQR, interquartile range; OR, odds ratio.
Table. Two-week postoperative venogram results
Variable
Symptomatic side, No. (%)
NC (n ¼ 33) (n ¼ 29) VA (n ¼ 70) AT (n ¼ 8)
Open 15 (45) 15 (52) 22 (31) 2 (25)
Stenosis (dilated) 11 (33) 9 (31) 37 (53) 4 (50)
Occluded 7 (21) 5 (17) 11 (16) 2 (25)
AT, Acute thrombus; NC, no compression; VA, venous ablation; VC,
venous compression.Author Disclosures: E. D. Gifford: None; V. Nguyen:None; A. H. Kaji:
None; P. Chisum: None; J. Kim: None; A. Zeng: None; R. Dukkipati:
None; C. deVirgilio: None.
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Objective: Although preoperative ultrasound (pre-op US) vein map-
ping is often used to determine patient eligibility for ﬁstula creation, tech-
nical inaccuracies may erroneously exclude patients. A policy of routine
intraoperative assessment of all patients, despite poor pre-op US, may lead
to greater ﬁstula creation rates but higher failure rates. This study evaluated
whether pre-op US vein mapping or intraoperative assessment is better
correlated with ﬁstula success.
Methods: Between February 2007 and July 2012, all autologous arte-
riovenous ﬁstulas (AVFs) created at a single Veterans Administration Med-
ical Center were examined. Access maturation, patency, and failure rates
were determined. Pre-op US vein mapping was used to classify patients as
good (vein >3 mm) or poor candidates (<3 mm). Intraoperative assessment
of the veins was routinely performed, and patients were classiﬁed as good or
poor candidates qualitatively. Outcomes were compared based on pre-op
US vein mapping and intraoperative evaluation.
Results: Over the 5-year time period, 387 ﬁstulas were created in
361 patients (mean age, 64 6 10 years; body mass index, 28 6 7 kg/m2).
In patients with preoperative vein sizes of <3 mm (36% of patients)or $3 mm (64%), the maturation and overall failure rates were 71%
vs 75% (P ¼ .61) and 68% vs 58% (P ¼ .15), respectively. In patients
with assessments of poor (14% of patients) or good veins (86%) at time
of operation, the maturation and overall failure rates were 42% vs 82%
(P < .001) and 86% vs 54% (P < .001). Those with poor veins under-
went intraoperative dilation more frequently (31% vs 6%, P < .001). In
patients with small preoperative vein size (<3 mm), intraoperative
assessment of good quality vessels was associated with a 73% maturation
rate.
Conclusions: Intraoperative assessment but not preoperative vein
mapping appears to be more accurately associated with maturation and
overall failure rates. Therefore, even in patients with inadequate preopera-
tive vein mapping, surgical intraoperative assessment may still be warranted.
Author Disclosures: K. P. Nguyen: None; T. Teruya: None; N. Sheng:
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Objective: This study reviewed preoperative and postoperative duplex
scans and postoperative venograms in patients with subclavian vein throm-
bosis who underwent ﬁrst rib resection and scalenectomy (FRRS) during
2005 to 2013.
Methods: Preoperative venous duplex scans revealed no compres-
sion (NC), venous compression (VC, $50% decrease in velocity on
abduction), venous ablation (VA, 0 velocity on abduction), and acute
thrombus (AT, 0 velocity on abduction and adduction). Correlation
with 2-week postoperative venograms (open, stenosis requiring dilata-
tion, or occluded) and postoperative (2-4, 6-8, and 12-month) duplex
scans was performed.
Results: Of 215 patients treated with FRRS, 140 had an ipsilateral
preoperative duplex scan and postoperative venogram. Twenty-nine pa-
tients (21%) had VC, 70 (50%) had VA, 8 (5.7%) had AT, and 33
(24%) had NC. Patients with preoperative NC or VC were more likely
to have an open vein on venogram (P < .02; Table). At 6 to 8 months
after FRRS, patients with preoperative VA were more likely to have
compression or ablation (P < .01); no difference was seen at 1 year.
Patency rates at last follow-up were 100% in the preoperative VC and AT
groups and 97% in those with VA or NC. A total of 128 preoperative scans
of the asymptomatic side revealed 67 patients (52%) had NC, 29 (23%)
had VC, 32 (25%) had VA, and none had AT. Patients with NC, VC, or
VA were signiﬁcantly more likely to have the same result on the opposite
side (P < .05).
Conclusions: Postoperative duplex scans reveal VC and VA resolve
during the year after FRRS, obviating the need for repeat venograms or
intervention. Patency rates are excellent in all patients when postoperative
venography directs the intervention. Patients with NC, VC, or VA on pre-
operative scans often show the same result on the opposite side.Author Disclosures: M. S. Orlando: None; K. C. Likes: None; Y. Lum:
None; J. A. Freischlag: None.
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Objective: The introduction of carotid stenting has led to a rapid
rise in the number of specialists performing this procedure. The
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(CREST) trial showed that carotid stenting can be performed with
an equivalent major event rate compared with carotid endarterectomy.
However, there is still controversy regarding the training and experi-
ence required to safely perform this procedure. This observational
study examined the performance of carotid stenting with regard to spe-
cialty and case volume.
Methods: From 2004 to 2011, data for patients diagnosed with ca-
rotid stenosis who had a carotid stenting procedure were extracted from
the Nationwide Inpatient Sample database. The cohort was separated based
on the provider performing the procedure (surgeon vs interventionalist),
hospital location, and volume. Surgeons were deﬁned as providers who
also performed a carotid endarterectomy or femoral-popliteal bypass during
the same time interval. Primary end points analyzed included stroke,
myocardial infarction, 30-day mortality. Length of stay and hospital costs
were also analyzed as secondary outcomes.
Results: A total of 20,663 cases of carotid stenting were found, of
which 15,305 (74%) were identiﬁed to have been performed by a “sur-
geon,” whereas 5358 (26%) were done by an “interventionalist.” Most
cases were done at hospitals in urban locations (96.51%) and designated
teaching institutions (61.47%). Unadjusted outcomes were similar be-
tween surgeons and interventionalist in stroke (4.33% and 4.41%),
myocardial infarction (2.10% and 2.13%), and mortality (0.84% and
1.03%), respectively. Qualitatively, volume per 10 cases was shown to
decrease the risk of stroke. Adjusted multivariate analysis demonstrated
no statistical signiﬁcance between the primary end point outcomes.
However, length of stay (2.81 vs 3.08 days) and total charges
($48,087.61 vs $51,718.77) were lower for procedures performed by
surgeons (Table).
Conclusions: Surgeons are performing the majority of carotid stent
procedures in the United States. The volume of cases performed by a pro-
vider, rather than the provider’s specialty, appears to be a stronger predictor
of adverse outcomes for carotid stenting. There was, however, signiﬁcant
cost differences between surgeons and interventionalists, which needs to
be further evaluated at an institutional level.Table. Carotid stent outcomes based on provider and hospital volume
Variable Adjusted risk/mean (95% CI) P
In-hospital mortality
Interventionist vs surgeon 1.29 (0.90-1.84) .1728
10-unit volume difference 1.01 (0.96-1.05) .7767
Stroke (CVA)
Interventionist vs surgeon 1.00 (0.84-1.19) .9819
10-unit volume difference 0.97 (0.94-0.99) <.005
Myocardial infarction
Interventionist vs surgeon 1.14 (0.90-1.43) .2803
10-unit volume difference 0.99 (0.96-1.02) .6010
Length of stay, days
Interventionist vs surgeon 0.29 (0.14-0.44) <.005
10-unit volume difference 0.05 (0.06 to 0.04) .0000
Total charge, $
Interventionist vs surgeon 2943.90 (1321.96-4565.84) <.005
10-unit volume difference 98.39 (55.77 to 252.55) .2110
CI, Conﬁdence interval; CVA, cerebrovascular accident.Author Disclosures: MD Sgroi: None; N. Kabutey: None; A. R.
Barleben: None; J. S. Lane: None; R. M. Fujitani: None.
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Objective: To determine the predictors and consequences of hemo-
dynamic instability (HI) after carotid artery stenting (CAS).
Methods: The records of all patients undergoing CAS in a single insti-
tution were reviewed. Patient demographics and risk factors were recorded.
Indications for CAS, medications (ie, statins, atropine, and b-blockers),
anatomic risk factors, balloon and stent length and diameter, as well as de-
gree of stenosis were noted. The presence of periprocedural hypertension
(systolic blood pressure >180 mm Hg), hypotension (systolic blood pres-
sure <90 mm Hg), and bradycardia (heart rate <60 beats/min) lasting
>1 hour was documented, as was more transient HI. Rates of transient
ischemic attack (TIA), stroke, myocardial infarction, and death within 30
days of the procedure were calculated. c2 Analysis was used to determinethe role of periprocedural factors in predicting the risk of HI and to deter-
mine if patients experiencing HI were more likely to suffer major adverse
events (MAE) than those who did not.
Results: Between 2005 and 2012, 199 CAS were performed in 191
patients (117 men, 74 women). Their mean age was 73.6 years (range,
46-92 years), and 87% had hypertension, 48.5% were smokers, 48% had cor-
onary disease, and 38% were diabetic. CAS was performed for asymptomatic
stenosis in 56% of patients, 24% had previous TIA, and 20% had previous
stroke. Statins were used by 63% of patients, b-blockers by 41.4%, and
92% received atropine before balloon dilatation or stent placement. Overall,
130 patients (65.3%) experienced HI, and 67 (33.7%) experienced HI last-
ing >1 hour. Octogenarians were more likely to suffer both transient and
prolonged HI, angina or contralateral occlusion were associated with an in-
crease in overall HI, and female sex was predictive of prolonged HI alone.
Transient HI was not predictive of MAE. Patients with HI persisting >1
hour were more likely to suffer a TIA than those who did not (P ¼
.045), but they were no more likely to experience stroke, myocardial infarc-
tion, or death (P > .35 for each).
Conclusions: Periprocedural HI occurs frequently during CAS, even
with prophylactic atropine administration. Although patients experiencing
HI were more likely to suffer a TIA, its presence is not associated with an
increase in stroke, myocardial infarction, or death.
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Objectives: Cranial nerve injury (CNI) is the most common neuro-
logic complication of carotid endarterectomy (CEA) and can cause signiﬁ-
cant chronic disability. Nonetheless, data from prior randomized trials are
limited. The incidence of CNI, baseline and procedural characteristics, out-
comes, and quality of life (QOL) scores were evaluated in 1151 patients ran-
domized to CEA.
Methods: Patients with CNI were identiﬁed and classiﬁed using Case
Report Forms, adverse event data, and clinical notes. Baseline and proce-
dural characteristics were compared using descriptive statistics. Clinical out-
comes at 1 and 12 months were analyzed. All data were adjudicated by two
neurologists and a vascular surgeon. QOL was evaluated using the SF-36 to
assess general health and Likert scales for disease speciﬁc outcomes at 2
weeks, 4 weeks, and 12 months after CEA. The effect of CNI on SF-36 sub-
scales was evaluated using random effects growth curve models, and Likert
scale data was compared by logistic regression.
Results: CNI was identiﬁed in 53 patients (4.6%). Nerves injured
were VII in 30.2%, XII in 24.5%, IX/X in 41.5%, and 3.8% had Horner syn-
drome. No baseline or procedural factors were predictive of CNI. Deﬁcits
resolved in 18 patients (34%) at 1 month and in 41 of 51 patients
(80.4%) with 1-year follow-up. One-year outcome could not be determined
in 2 patients. Classifying those patients as unresolved results in persistent
CNI in 22.6% of patients at 1 year. QOL evaluation by SF-36 showed no
statistical difference between groups with and without CNI at 2 weeks, 4
weeks, and 1 year. By Likert scale analysis, the group with CNI showed a
signiﬁcant difference in the difﬁculty eating/swallowing parameter at 2
and 4 weeks but not at 1 year (P ¼ .0001).
Conclusions: In CREST, CNI occurred in 4.6% of patients undergo-
ing CEA, with 34% resolution at 30 days and 77.4% at 1 year. CNI had a
small effect on QOL, negatively impacting only difﬁculty eating/swallowing
at 2 and 4 weeks but not at 1 year.
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